Skip to content

November, 2026

Birr Metrics
Birr Metrics
  • News
  • Feature
  • Insights
  • Interview
  • Startups
  • Editorial
  • Digital Magazine
Search
Birr Metrics
Birr Metrics
  • News
  • Feature
  • Insights
  • Interview
  • Startups
  • Editorial
  • Digital Magazine

Swiss Firms Shift Operations Abroad as U.S. Tariffs Prompt Investment Moves

Mintesinot Nigussie
December 6, 2025

Swiss exporters are relocating parts of their operations overseas following adjustments to U.S. tariffs, with many firms planning to move production or increase investment abroad, according to a survey by business association economiesuisse. Despite a recent agreement reducing U.S. duties from 39 percent to 15 percent, nearly a third of surveyed companies said they intend to expand investment outside Switzerland and shift production overseas.

Some firms are exploring relocation beyond both the European Union and the United States, while others are assessing new markets, adjusting prices, or pausing U.S.-bound exports. Economiesuisse’s chief economist, Rudolf Minsch, said Switzerland remains attractive for business, though some companies are seeking alternative production bases to manage costs.

Ethiopia maintains established diplomatic and economic ties with Switzerland, dating back to 1952, supported by agreements including a double taxation treaty. Bilateral trade reached approximately CHF 77 million in 2024, with Ethiopia exporting mainly agricultural products, including coffee, and importing machinery, pharmaceuticals, and technical equipment.

Experts say the Swiss shift could influence global investment flows. Firms seeking lower-cost production bases may increasingly consider emerging markets such as Ethiopia. A reduction in outbound Swiss investment could affect capital inflows and technology transfer, while the country’s ability to attract relocated production will depend on regulatory stability, infrastructure, and investment policies.

Pharmaceuticals, Switzerland’s largest export sector, are central to these shifts. UBS projects that relocating all U.S.-bound Swiss pharmaceutical production could reduce Swiss economic growth over five years from 10 percent to 7.7 percent, illustrating the strategic considerations companies weigh when reorganising global production.

Share:

More News

National Bank of Ethiopia
NBE Proposes 10,000 Birr Fine Per Share for Unauthorised Bank Acquisitions

Draft directive would invalidate non-compliant share transactions and impose penalties on banks, with fines reaching 10 million birr for every 1,000 s

Read More
National Bank of Ethiopia liquidity absorption and maturing central bank deposit concept.
Foreign Banks With 10 Billion US Dollars in Assets Could Fully Acquire Ethiopian Banks

Draft directive sets conditions for 100 percent foreign takeovers Foreign banks could acquire up to 100 percent ownership of existing Ethiopian commer

Read More
Global Aviation Needs 200-Fold Surge in Sustainable Fuel
Global Aviation Needs 200-Fold Surge in Sustainable Fuel Production to Meet 2050 Climate Goal

Green aviation fuel accounts for less than one percent of global consumption as governments push for investment, harmonised regulations and expanded p

Read More
NBE Presses Banks to Close Financial Service Gaps
NBE Presses Banks to Close Financial Service Gaps in Ethiopia’s Special Economic Zones

Central bank demands practical measures as stricter banking rules take effect across investment hubs developed with more than 1.5 billion US dollars i

Read More

Share your love

Menu
  • News
  • Feature
  • Insights
  • Interview
  • Startups
  • Editorial
  • About us
  • Digital Magazine
  • Privacy Policy

hello@birrmetrics.com

Copyright © 2026 Birr Metrics | All Rights Reserved

Designed By Collab Systems

Scroll to Top